Galectin Therapeutics To Present At The RedChip Small-Cap Equities Virtual Conference

Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it will present at the RedChip Small-Cap Equities Virtual Conference.

The Company’s presentation will be webcast live at http://www.redchip.com on August 30, 2012, beginning at 10:30 AM Eastern time. To register for the conference, please visit http://www.redchip.com/virtualconference. Please log on approximately 10 minutes before the start of the conference to ensure a timely connection.

Galectin Therapeutics will deliver a 30-minute corporate presentation. Investors will have the opportunity to speak with Company executives during a 15-minute question-and-answer session following the presentation. An archive of the presentation will be available in the Investor’s section of the Company’s website: www.galectintherapeutics.com.

About Galectin Therapeutics

Galectin Therapeutics (NASDAQ: GALT) is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, key mediators of biologic function. The Company is leveraging extensive scientific and development expertise as well as established relationships with external sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer. Additional information is available at www.galectintherapeutics.com.

Copyright Business Wire 2010

If you liked this article you might like

Galectin Therapeutics (GALT) Stock Drops on Drug Failure, Downgraded

Galectin Therapeutics (GALT) Stock Drops on Drug Failure, Downgraded

Galectin Therapeutics (GALT) Stock Declines on Drug Failure, Rating Cut

Galectin Therapeutics (GALT) Stock Declines on Drug Failure, Rating Cut

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These Biotech Names Are on My Radar

These Biotech Names Are on My Radar

Top Swing Trade Ideas for Monday: Cerus, Endocyte, More

Top Swing Trade Ideas for Monday: Cerus, Endocyte, More